Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9…
The world says ‘NamAIste’ to Made in India’s world’s first Hospitality GPT by IIHM
AI-powered knowledge engine built on deep domain research is the global hospitality…
